STAPHYLOCOCCUS TOXOID

Abstract
To the Editor:— May we offer the following data to support the conclusions reached by Kindel and Costello in their study of staphylococcus toxoid in the treatment of pusular dermatoses (The Journal, April 21, p. 1287). We, too, have treated but a small number of patients, but our results, like theirs, were so definitely unsatisfactory that we feel impelled to record them, especially since commercially prepared toxoids are gaining wide use. Our patients were from the Department of Dermatology, University of Illinois College of Medicine. We treated about fifty patients, of whom only twenty-three received the minimum dosage recommended by Dolman. This group included twelve cases of pustular acne vulgaris, five of sycosis barbae coccygenica, four of furunculosis, one of pustular folliculitis of the scalp and one of dissecting cellulitis of the scalp (perifolliculitis capitis abscedens et suffodiens). The toxoid material was prepared essentially according to the specifications outlined by